Latest Articles

Publication Date
With help from a nanoparticle, WA researchers find possible endometriosis treatment - KOIN.com

With help from a nanoparticle, WA researchers find possible endometriosis treatment KOIN.com

Published: Sept. 26, 2026, 3 p.m.
With help from a nanoparticle, WA researchers find possible endometriosis treatment - koin.com

With help from a nanoparticle, WA researchers find possible endometriosis treatment koin.com

Published: Sept. 26, 2026, 3 p.m.
Digital Patient Decision Aids for Endometriosis Management: A Scoping Review.

Endometriosis treatment requires women to navigate complex, preference-sensitive decisions. Patient Decision Aids (PtDAs) help patients make value-aligned choices. However, the scope and quality of digital PtDAs for endometriosis, and the …

Published: Sept. 26, 2026, midnight
Current Evidence and Emerging Directions in Endometriosis Pharmacotherapy: A Systematic Review of Recent Advances.

Background: Endometriosis affects 190 million women worldwide, so there is a need for accessible and more comprehensive knowledge regarding the pharmacotherapeutic options that can be offered to patients. This systematic …

Published: Sept. 17, 2026, midnight
TCM Treatment of Endometriosis: Pathogenesis, Mechanism and Clinical Practice.

Endometriosis (EMs) is a chronic neuroinflammatory disorder prevalent in women of reproductive age characterized by heterogeneous clinical manifestations, while conventional Western therapies are limited by obvious adverse reactions and unsatisfactory …

Published: Sept. 9, 2026, midnight
Exosomal miR-22-3p targets p53 to regulate endometrial epithelial cell function in the pathogenesis of endometriosis.

Endometriosis (EMs) is a widespread gynecological disease, affecting approximately 6-10% of females of child-bearing age. Despite its significant influence on women's health, the specific pathophysiology remains unclear. The enrichment of …

Published: Sept. 4, 2026, midnight
Endometriosis Treatment Market to Reach USD 3.1 Billion by 2034, - openPR.com

Endometriosis Treatment Market to Reach USD 3.1 Billion by 2034, openPR.com

Published: Aug. 31, 2026, 11:31 a.m.
2-Deoxyglucose Dendrimer-Enabled Niclosamide Delivery to FRβ-Expressing Macrophages Alleviates Endometriosis Progression and Associated Hyperalgesia.

Endometriosis (EuE) is a chronic, incurable disease. Due to limited efficacy, high recurrence rates, and serious side effects of current treatments, development of new, targeted, nonhormonal therapies is urgently needed. …

Published: Aug. 30, 2026, midnight
Why Estrogen Suppression Anchors Endometriosis Treatment - Patient Care Online

Why Estrogen Suppression Anchors Endometriosis Treatment Patient Care Online

Published: Aug. 19, 2026, 1:09 p.m.
Why Estrogen Suppression Anchors Endometriosis Treatment - Contemporary OB/GYN

Why Estrogen Suppression Anchors Endometriosis Treatment Contemporary OB/GYN

Published: Aug. 19, 2026, 12:07 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!